Stockreport

AC Immune launches preclinical trials for anti-TDP-43 antibody in neurodegenerative diseases [Seeking Alpha]

AC Immune SA  (ACIU) 
Last ac immune sa earnings: 11/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acimmune.com/en/investors
PDF AC Immune(NASDAQ:ACIUTDP-43 pathology is associated with cognitive decline and episodic memory loss in neurodegenerative diseases.The antibody binds all forms of TDP-43 [Read more]